Le Lézard

Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, and Eisai Co., Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a ...
Sweetwater Reporter

AAR reports second quarter fiscal year 2026 results

WOOD DALE, Ill., Jan. 6, 2026 /PRNewswire/ -- (NYSE: AIR), a leading provider of aviation services to commercial and ...

CSPi (CSPI) Q4 2025 Earnings Call Transcript

Thank you, Matthew, and hello, everyone, and thank you for joining us to review CSPi's financial results for the fiscal 2025 ...

McGraw Hill, Inc. Announces CEO Succession Plan

McGraw Hill, Inc. (NYSE: MH) ("McGraw Hill" or the "Company"), a leading global provider of education solutions for K-12, ...
The Malaysian Reserve

Aritzia Reports Third Quarter Fiscal 2026 Financial Results

Aritzia expects the following for the fourth quarter of Fiscal 2026: ...
The Island

Iran leader says anti-government protesters are vandals trying to please Trump

Iran’s Supreme Leader Ayatollah Ali Khamenei has called anti-government protesters “troublemakers” and “a bunch of vandals” ...

AAR CORP.: AAR reports second quarter fiscal year 2026 results

AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs ...
Le Lézard

AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving ...